When a pharmaceutical company provides a positive update with regards to any of its products, then the stock almost always rises, and that is what has happened with MEIP stock.
Positive DevelopmentMEI Pharma Inc (NASDAQ:MEIP) provided updated data from the clinical trial of one of its products, and after the news emerged, MEIP stock jumped by as much as 8% in early trade on Friday. The medicine in question is ME-401, which is meant for the treatment of people suffering from indolent B-cell malignancies. The data relates to the Phase 1B study of the product, ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.